MITRA — Mithra Pharmaceuticals SA Cashflow Statement
0.000.00%
Last trade - 00:00- €15.62m
- €212.50m
- €40.16m
Annual cashflow statement for Mithra Pharmaceuticals SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 35 | -83.7 | -87.9 | -26.2 | — |
| Depreciation | |||||
| Non-Cash Items | -34.9 | 5.34 | -3.09 | -11.1 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -52.6 | -11.5 | 6.15 | -31.4 | -2.18 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -46.8 | -80 | -74.4 | -56.8 | -2.18 |
| Capital Expenditures | -15.5 | -16.2 | -21.2 | -25.7 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -5 | 0.023 | -33.5 | 0.168 | 3.45 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -20.5 | -16.2 | -54.7 | -25.5 | 3.45 |
| Financing Cash Flow Items | 4.13 | 124 | -12.5 | -10.9 | -20.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.95 | 185 | 23.2 | 77.9 | -20.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -69.2 | 89 | -106 | -4.59 | -19.3 |